BioMed Research International

Advances in Localized Prostate Cancer Management


Lead Editor

1Lenox Hill Hospital, New York, USA

2Mount Sinai Medical Center, New York, USA

3North Shore Long Island Jewish Hospital, New York, USA

4Tanta University, Tanta, Egypt

Advances in Localized Prostate Cancer Management


Despite the comment of United States Preventive Task Force against the screening use of PSA in detection of prostate cancer in general population, the number of estimated prostate cancer cases in 2016 still demonstrates prostate cancer as the most common cancer in men. Nevertheless, the decrease in number of estimated cases in 2016 might be a reflection of decreased use of PSA. However, more men are diagnosed with localized prostate cancer each year. Advances in technology has introduced new opportunities in treatment of localized prostate cancer. The concept of “Active Surveillance” is emerging in care of prostate cancer with the development of new high quality imaging technologies (i.e., MRI, PET). Genetic tests are growing on the market to predict the behavior of malignant cells and new lab markers are evolved to mark aggressive prostate cancer at early stages. Localized treatments are increasing in population with introduction of HIFU, CyberKnife, and NanoKnife.

This special issue aims to cover the topics in management of localized prostate cancer via basic science or clinical or epidemiological studies along with original research articles and systematic review articles and meta-analyses.

Potential topics include but are not limited to the following:

  • Imaging in prostate cancer: MRI, PET, and so forth
  • Genetic tests in prostate cancer: clinical use, cost, and application
  • Novel markers in prostate cancer diagnosis
  • Robotic surgery in localized prostate cancer
  • HIFU in prostate cancer: indications, outcomes, and complications
  • Role of radiation in localized prostate cancer
  • Debates in use of PSA as screening tool
  • Treatment of prostate cancer in young men
  • Active surveillance in prostate cancer: indications, outcomes, and practical note


  • Special Issue
  • - Volume 2018
  • - Article ID 2807813
  • - Editorial

Advances in Localized Prostate Cancer Management

David B. Samadi | Michael A. Feuerstein | ... | Yasser Farahat
  • Special Issue
  • - Volume 2017
  • - Article ID 7617148
  • - Research Article

The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy

Chao-Hsiang Chang | Hung-Chieh Chiu | ... | Po-Fan Hsieh
  • Special Issue
  • - Volume 2017
  • - Article ID 1467056
  • - Research Article

Influence of Men’s Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer

Elyse Reamer | Felix Yang | ... | Jinping Xu
  • Special Issue
  • - Volume 2017
  • - Article ID 9858923
  • - Research Article

Long-Term Oncological Outcomes for Young Men Undergoing Radical Prostatectomy for Localized Prostate Cancer

Daimantas Milonas | Zilvinas Venclovas | ... | Aivaras Jonas Matjosaitis
  • Special Issue
  • - Volume 2016
  • - Article ID 6829875
  • - Review Article

Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?

Ben G. L. Vanneste | Evert J. Van Limbergen | ... | Philippe Lambin
  • Special Issue
  • - Volume 2016
  • - Article ID 2384894
  • - Research Article

Diagnostic Accuracy of Robot-Guided, Software Based Transperineal MRI/TRUS Fusion Biopsy of the Prostate in a High Risk Population of Previously Biopsy Negative Men

Malte Kroenig | Kathrin Schaal | ... | Cordula A. Jilg
BioMed Research International
 Journal metrics
See full report
Acceptance rate16%
Submission to final decision80 days
Acceptance to publication21 days
Journal Citation Indicator-
Impact Factor-

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.